Lifestyle Modification and Blood Pressure Study (LIMBS)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to compare the effects of 24 weeks of either a blood pressure education and walking program versus a yoga exercise program versus the combined intervention of blood pressure education and yoga on reducing mild to moderate high blood pressure in pre-hypertension and stage 1 hypertension subjects.
| Condition | Intervention | Phase |
|---|---|---|
|
High Blood Pressure |
Behavioral: Yoga exercise program Behavioral: Blood pressure education/walking program |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | Lifestyle Modification and Blood Pressure Study |
- 24-hour ambulatory blood pressure [ Time Frame: baseline, 12 weeks, 24 weeks ] [ Designated as safety issue: Yes ]
- Cerebral blood flow [ Time Frame: baseline, 12 weeks, 24 weeks ] [ Designated as safety issue: No ]
- Urinary Isoprostane [ Time Frame: baseline, 12 weeks, 24 weeks ] [ Designated as safety issue: No ]
- serum asymmetric dimethylarginine (ADMA) [ Time Frame: baseline, 12 weeks, 24 weeks ] [ Designated as safety issue: No ]
- salivary cortisol [ Time Frame: baseline, 12 weeks, 24 weeks ] [ Designated as safety issue: No ]
- psychological measures of mood, perceived stress and health competence [ Time Frame: baseline, 12 weeks, 24 weeks ] [ Designated as safety issue: No ]
- physiological measures of flexibility [ Time Frame: baseline, 12 weeks, 24 weeks ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 120 |
| Study Start Date: | August 2009 |
| Estimated Study Completion Date: | August 2013 |
| Estimated Primary Completion Date: | August 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Active Comparator: Blood pressure education/walking program |
Behavioral: Blood pressure education/walking program
The program will consist of small group health education classes and a walking program. Subjects will be expected to attend a dietician-led nutrition class twice a month. On alternate weeks the subjects will be given either motivational talks about a variety of topics including weight loss, walking programs, and healthy lifestyle choices or they will be given educational DVDs or literature to read on the weeks that they are not attending a BPEP class. These subjects will all receive 12 nutrition classes and 12 motivational experiences. The subjects will also be expected to walk 6 days a week gradually increasing to 180 minutes of walking per week or 10,000 steps per day.
Other Name: BPEP
|
| Active Comparator: Combined intervention |
Behavioral: Yoga exercise program
Subjects in the yoga exercise program participate in structured bi-weekly 1.5 hour yoga classes held at a yoga studio as well as develop a weekly hour-long home practice over the 6 months of the study.
Other Name: YP
Behavioral: Blood pressure education/walking program
The program will consist of small group health education classes and a walking program. Subjects will be expected to attend a dietician-led nutrition class twice a month. On alternate weeks the subjects will be given either motivational talks about a variety of topics including weight loss, walking programs, and healthy lifestyle choices or they will be given educational DVDs or literature to read on the weeks that they are not attending a BPEP class. These subjects will all receive 12 nutrition classes and 12 motivational experiences. The subjects will also be expected to walk 6 days a week gradually increasing to 180 minutes of walking per week or 10,000 steps per day.
Other Name: BPEP
|
| Experimental: Yoga Exercise Program |
Behavioral: Yoga exercise program
Subjects in the yoga exercise program participate in structured bi-weekly 1.5 hour yoga classes held at a yoga studio as well as develop a weekly hour-long home practice over the 6 months of the study.
Other Name: YP
|
Detailed Description:
The study is a non-blinded, randomized controlled trial to assess the safety and efficacy of 24 weeks of a structured yoga exercise program (YP) versus a blood pressure education and walking program (BPEP) versus the combined intervention on reducing mild to moderate high blood pressure in adults with pre-hypertension or stage 1 hypertension. This will be done through a single center trial using a parallel design. All potential subjects will be screened first by telephone and then by 2 outpatient visits at the Clinical and Translational Research Center (CTRC) at the hospital of the University of Pennsylvania. Eligible subjects will then make 3 visits to the CTRC where they will be admitted overnight to have non-invasive 24-hour recordings of BP, as well as have periodic blood, urine and saliva collections. The entire study duration is 28 weeks (24 weeks post-randomization) and includes a total of 7 evaluation visits (including 2 functional magnetic resonance imaging visits) and a termination visit. Subjects will be randomized to YP, BPEP or the combined intervention of YP and BPEP.
Eligibility| Ages Eligible for Study: | 18 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Subjects must be willing and able to give written informed consent.
- Age > 18 years, but < 75 years.
- BP criteria: Systolic Blood Pressure (SBP) of > 130, but < 160 mm Hg.
- Willing to comply with all study-related procedures.
Exclusion Criteria:
- Subjects who are pregnant or post partum < 3 months.
- Subjects currently taking BP lowering medications or dietary supplements (magnesium, potassium, calcium > 1200 mg/day, fish oils, ephedra, hawthorn, forskolin, etc…).
- Stage II HTN (SBP > 160 mmHg OR diastolic blood pressure (DBP) > 100 mmHg).
- Non-dominant arm circumference > 50 cm.
- BMI > 40.0 kg/m2.
- Practicing yoga >1x/month in the previous 6 months.
- Received/used experimental drug or device within 30 days prior to screening, or donated blood > 1 pint within 8 weeks of screening.
- Diabetes mellitis.
- Established cardiovascular disease.
- Known arrhythmias or cardiac pacemakers.
- Current users (within 30 days) of any tobacco products.
- History of renal insufficiency (glomerular filtration rate < 60 ml/min).
- Women consuming > 7 alcoholic drinks/week; men consuming > 14 drinks/week.
- Known autonomic neuropathy.
- Known secondary cause of HTN (renal artery stenosis, pheochromocytoma, coarctation of aorta, hyperaldosteronism).
- Benzodiazepine, anti-psychotic drugs (3 month stable use of SSRIs are allowed), or steroid use.
- Known severe musculoskeletal problems such as spinal stenosis that may limit participation in yoga.
- Use of other mind/ body therapies such as Qi Gong, Tai Chi, meditation.
- Lack Internet access.
- Presence of non-removable metallic foreign object, surgically implanted electrical device, surgically placed metallic clip (aneurysm clip), ear implants, any history of metal implants in the eye.
Contacts and Locations| Contact: Anne Bowler, BA | 215-615-6570 | Anne.Bowler@uphs.upenn.edu |
| Contact: Debbie Cohen, M.D. | 215-615-0794 | Debbie.Cohen@uphs.upenn.edu |
| United States, Pennsylvania | |
| Hospital at the University of Pennsylvania | Recruiting |
| Philadelphia, Pennsylvania, United States, 19104 | |
| Principal Investigator: Debbie Cohen, M.D. | |
| Principal Investigator: | Debbie Cohen, M.D. | University of Pennsylvania |
More Information
Additional Information:
Publications:
| Responsible Party: | Debbie Cohen, M.D., University of Pennsylvania |
| ClinicalTrials.gov Identifier: | NCT00964847 History of Changes |
| Other Study ID Numbers: | R01AT004921-01A1 |
| Study First Received: | August 24, 2009 |
| Last Updated: | August 4, 2011 |
| Health Authority: | United States: Institutional Review Board United States: Federal Government |
Keywords provided by University of Pennsylvania:
|
hypertension cardiovascular disease yoga |
Additional relevant MeSH terms:
|
Hypertension Vascular Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on May 23, 2013